| Literature DB >> 35444272 |
Ankita Mukherjee1, Rakesh Parashar2.
Abstract
BACKGROUND/Entities:
Year: 2022 PMID: 35444272 PMCID: PMC9020425 DOI: 10.1038/s41430-022-01147-w
Source DB: PubMed Journal: Eur J Clin Nutr ISSN: 0954-3007 Impact factor: 4.884
Selected indicators on child health conditions from NFHS and definitions.
| Indicators | Definition |
|---|---|
| Prevalence of diarrhoea in the 2 weeks preceding the survey for children under 5 years (%) | Three or more loose or liquid stools per day |
| Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey for children under 5 years (%) | Cough accompanied by short, rapid breathing that is chest related and/or difficult breathing which is chest related |
| Children under 5 years who are stunted (height-for-age) (%) | Below −2 standard deviations, based on the WHO standard. |
| Children under 5 years who are wasted (weight-for-heigh | Below −2 standard deviations, based on the WHO standard. |
| Children under 5 years who are severely wasted (weight-for-height) (%) | Below −3 standard deviations, based on the WHO standard |
| Children under 5 years who are underweight (weight-for-age) (%) | Below −2 standard deviations, based on the WHO standard. |
| Children under 5 years who are overweight (weight-for-height) (%) | Above +2 standard deviations, based on the WHO standard. |
| Children age 6–59 months who are anaemic (<11.0 g/dl) (%) | Haemoglobin in grams per decilitre (g/dl). Among children, prevalence is adjusted for altitude. Estimated using the capillary blood. |
Prevalence of outcome indicators in children under five years.
| Outcome indicators | Prevalence of diarrhoea ~ (%) | Prevalence of ARI symptoms~ (%) | Prevalence of stunting (%) | Prevalence of wasting (%) | Prevalence of severely wasted (%) | Prevalence of underweight (%) | Prevalence of overweight (%) | Prevalence of anaemia (%) | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NFHS 3 | NFHS 4 | NFHS 5 | NFHS 3 | NFHS 4 | NFHS 5 | NFHS 3 | NFHS 4 | NFHS 5 | NFHS 3 | NFHS 4 | NFHS 5 | NFHS 3 | NFHS 4 | NFHS 5 | NFHS 3 | NFHS 4 | NFHS 5 | NFHS 3 | NFHS 4 | NFHS 5 | NFHS 3 | NFHS 4 | NFHS 5 | |
| 8.1 | 2.9 | 5.5 | 7.3 | 1.0 | 2.5 | 46.5 | 36.4 | 35.3 | 13.7 | 17.0 | 21.7 | 4.0 | 6.2 | 9.1 | 36.4 | 29.8 | 32.8 | 0.3 | 2.3 | 4.9 | 69.6 | 35.7 | 68.4 | |
| 5.7 | 10.6 | 10.4 | 1.9 | 5.8 | 4.8 | 55.1 | 43.8 | 46.5 | 30.7 | 15.3 | 12.1 | 19.9 | 6.5 | 4.7 | 48.8 | 28.9 | 26.6 | 0.2 | 3.9 | 4.0 | 64.4 | 48.0 | 45.1 | |
| 9.9 | 5.8 | 5.6 | 4.7 | 1.7 | 1.8 | 35.6 | 28.9 | 23.4 | 9.0 | 6.8 | 9.9 | 2.1 | 2.2 | 3.4 | 22.1 | 13.8 | 13.3 | 0.5 | 3.1 | 3.4 | 44.2 | 23.9 | 42.8 | |
| 11.0 | 7.6 | 4.3 | 4.1 | 2.2 | 0.6 | 39.8 | 28.1 | 28.9 | 9.0 | 6.1 | 9.8 | 3.5 | 2.3 | 4.9 | 19.9 | 12.0 | 12.7 | 1.2 | 4.2 | 10.0 | 41.1 | 19.3 | 46.4 | |
| 6.4 | 5.1 | 3.4 | 4.2 | 1.4 | 1.1 | 38.8 | 28.6 | 32.7 | 13.3 | 11.3 | 19.1 | 5.2 | 4.2 | 7.9 | 25.2 | 16.7 | 26.9 | 0.8 | 3.8 | 4.9 | * | 26.4 | 42.7 | |
| 16.5 | 1.8 | 5.5 | 5.0 | 0.3 | 0.7 | 38.3 | 29.6 | 22.3 | 9.7 | 14.2 | 13.7 | 3.3 | 5.9 | 6.6 | 19.7 | 14.2 | 13.1 | 1.3 | 8.6 | 9.6 | 59.2 | 55.1 | 56.4 | |
| 8.3 | 4.9 | 6.2 | 14.2 | 2.6 | 1.3 | 35.7 | 24.3 | 32.3 | 24.6 | 16.8 | 18.2 | 8.6 | 6.3 | 7.3 | 39.6 | 24.1 | 25.6 | 0.1 | 3.0 | 8.2 | 62.9 | 48.3 | 64.3 | |
| 9.0 | 9.2 | 7.3 | 5.8 | 2.7 | 2.8 | 48.0 | 38.4 | 35.5 | 19.8 | 21.0 | 19.3 | 6.4 | 7.5 | 7.7 | 42.5 | 35.8 | 32.1 | 0.4 | 2.1 | 3.4 | 69.5 | 58.6 | 67.1 | |
~reported in the last 2 weeks of the survey; * indicates blood samples not collected due to local opposition.
Relative change from NFHS-3 to NFHS-5 of the studied health outcomes of all states (mean).
| Outcome indicators | Relative change | 95% CI | |
|---|---|---|---|
| LCI | UCI | ||
| −0.4* | −0.7 | −0.1 | |
| −0.7** | −0.1 | −0.4 | |
| −0.3** | −0.3 | −0.2 | |
| −0.3** | −0.5 | −0.2 | |
| −0.1 | −0.5 | 0.3 | |
| −0.1 | −0.9 | 0.6 | |
| 10.0** | 4.3 | 16.0 | |
| −0.1 | −0.2 | 0.1 | |
LCI lower confidence interval, UCI upper confidence interval.
*P < 0.05, **P < 0.001.
Fig. 1Relative change of child health outcomes by states.
A Diarrhoea, B ARI, C stunting, D underweight, E wasting, F severely wasting, G anaemia, H overweight. Note: The colours are graded from the highest improvements to the lowest in ascending order.
Average annual rate of reduction from NFHS-3, 4 and 5.
| Outcome indicators | Assam | Meghalaya | Manipur | Mizoram | Nagaland | Sikkim | Tripura |
|---|---|---|---|---|---|---|---|
| 4.1 | −4.9 | 4.3 | 5.8 | 4.5 | 10.0 | 2.7 | |
| 9.7 | −8.4 | 6.9 | 11.4 | 9.2 | −18.4 | 15.7 | |
| 1.5 | 1.5 | 2.7 | 2.5 | 1.7 | 3.2 | 1.3 | |
| −3.3 | 6.3 | 0.0 | 0.2 | −1.4 | −2.5 | 2.5 | |
| −5.5 | 10.2 | −3.1 | −0.8 | −2.5 | −5.3 | 1.9 | |
| 1.0 | 4.3 | 3.8 | 3.8 | 0.2 | 2.8 | 3.8 | |
| −22.1 | −26.0 | −15.5 | −15.5 | −14.2 | −16.4 | −37.6 | |
| 1.2 | 2.8 | 1.2 | 0.8 | −13.3a | 0.8 | −0.2 |
aTrend based on 4th and 5th round.
Fig. 2Distribution of the burden of health outcomes by place of residence.
Distribution of the burden of health outcomes by place of residence. The point difference of prevalence (urban and rural) for diarrhoea, ARI, stunting, wasting, severe wasting, underweight, overweight and anaemia are presented for the states (A) Assam, B Manipur, C Meghalaya, D Mizoram, E Nagaland, F Sikkim, G Tripura.